Insights

Expanding Product Portfolio Cara Therapeutics is actively launching new treatments like Kapruvia and advancing Phase 3 trials, opening opportunities for partnership and commercial sales.

Strategic Partnerships Recent partnership with Hcroyalty for non-dilutive financing indicates potential collaborations for expanding market reach and sales opportunities.

Board of Directors Enhancement Appointment of experienced professionals like Lisa von Moltke and Helen M. Boudreau to the Board brings new insights, guidance, and potential industry connections for boosting sales strategies.

Key Leadership Changes Appointment of new CEO Christopher Posner and CFO Ryan Maynard signal strategic shifts and fresh perspectives that could lead to innovative sales approaches and revenue growth.

Market Positioning & Revenue Growth Despite Q1 2023 net loss, Cara Therapeutics' market expansions in Europe, Phase 3 trials progress, and ESG report unveil a commitment to growth, sustainability, and potential sales scalability.

Cara Therapeutics Tech Stack

Cara Therapeutics uses 8 technology products and services including WordPress, Typekit, Google Charts, and more. Explore Cara Therapeutics's tech stack below.

  • WordPress
    Content Management System
  • Typekit
    Font Scripts
  • Google Charts
    Javascript Graphics
  • Modernizr
    Javascript Libraries
  • web-vitals
    Javascript Libraries
  • Swiper
    Javascript Libraries
  • Elementor
    Page Builders
  • HSTS
    Security

Media & News

Cara Therapeutics's Email Address Formats

Cara Therapeutics uses at least 1 format(s):
Cara Therapeutics Email FormatsExamplePercentage
flast@caratherapeutics.comJDoe@caratherapeutics.com
94%
first@caratherapeutics.comJohn@caratherapeutics.com
3%
first.last@caratherapeutics.comJohn.Doe@caratherapeutics.com
2%
last@caratherapeutics.comDoe@caratherapeutics.com
1%

Frequently Asked Questions

Where is Cara Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Cara Therapeutics's main headquarters is located at 400 Atlantic St Suite 500 Stamford, Connecticut 06901 US. The company has employees across 3 continents, including North AmericaEuropeSouth America.

What is Cara Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Cara Therapeutics's main corporate office by phone at +1-203-567-1500. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cara Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Cara Therapeutics is a publicly traded company; the company's stock symbol is CARA.

What is Cara Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Cara Therapeutics's official website is caratherapeutics.com and has social profiles on LinkedIn.

How much revenue does Cara Therapeutics generate?

Minus sign iconPlus sign icon
As of June 2024, Cara Therapeutics's annual revenue reached $35M.

What is Cara Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Cara Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cara Therapeutics have currently?

Minus sign iconPlus sign icon
As of June 2024, Cara Therapeutics has approximately 73 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Financial Officer: R. M.Chief Medical Officer: J. S.Chief Medical Officer: J. G.. Explore Cara Therapeutics's employee directory with LeadIQ.

What industry does Cara Therapeutics belong to?

Minus sign iconPlus sign icon
Cara Therapeutics operates in the Biotechnology Research industry.

What technology does Cara Therapeutics use?

Minus sign iconPlus sign icon
Cara Therapeutics's tech stack includes WordPressTypekitGoogle ChartsModernizrweb-vitalsSwiperElementorHSTS.

What is Cara Therapeutics's email format?

Minus sign iconPlus sign icon
Cara Therapeutics's email format typically follows the pattern of . Find more Cara Therapeutics email formats with LeadIQ.

How much funding has Cara Therapeutics raised to date?

Minus sign iconPlus sign icon
As of June 2024, Cara Therapeutics has raised $40M in funding. The last funding round occurred on Nov 02, 2023.

When was Cara Therapeutics founded?

Minus sign iconPlus sign icon
Cara Therapeutics was founded in 2004.
Cara Therapeutics

Cara Therapeutics

Biotechnology ResearchConnecticut, United States51-200 Employees

Cara Therapeutics is a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus. The Company is developing an oral formulation of difelikefalin, a selective, peripherally acting, non-scheduled kappa opioid receptor agonist, for the treatment of chronic pruritus associated with notalgia paresthetica (NP), a common, underdiagnosed neuropathy affecting the upper back for which there are no FDA-approved therapies. The Company is conducting a Phase 2/3 clinical program in NP with topline results of the dose-finding portion expected in the third quarter of 2024. Cara Therapeutics also developed an IV formulation of difelikefalin, which is approved in the United States, EU, and multiple other countries for the treatment of moderate-to-severe pruritus associated with advanced chronic kidney disease in adults undergoing hemodialysis. The IV formulation is out-licensed worldwide.

Section iconCompany Overview

Headquarters
400 Atlantic St Suite 500 Stamford, Connecticut 06901 US
Phone number
+1-203-567-1500
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
CARA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2004
Employees
51-200

Section iconFunding & Financials

  • $40M

    Cara Therapeutics has raised a total of $40M of funding over 10 rounds. Their latest funding round was raised on Nov 02, 2023.

  • $10M$50M

    Cara Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $40M

    Cara Therapeutics has raised a total of $40M of funding over 10 rounds. Their latest funding round was raised on Nov 02, 2023.

  • $10M$50M

    Cara Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.